Singapore Health Sciences Authority (HSA) has granted approval for Respiree’s 1Bio AI-Acute toolbox, classifying it as a Class B software-as-a-medical device (SaMD).

The toolbox is intended to assist healthcare professionals in detecting acute inpatient deterioration through machine learning (ML) and AI models.

Respiree noted that the toolbox is designed to deliver higher precision notifications for acute deterioration compared to existing standards of care.